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ABSTRACT
Objectives: One of Africa’s most important challenges
is to improve maternal and neonatal health. The
identification of groups at highest risk for adverse
pregnancy outcomes is important for developing and
implementing targeted prevention programmes. This
study assessed whether young adolescent girls constitute
a group at increased risk for adverse birth outcomes
among pregnant women in sub-Saharan Africa.
Setting: Data were collected prospectively as part of
a large randomised controlled clinical trial evaluating
intermittent preventive treatment of malaria in
pregnancy (NCT00811421—Clinical Trials.gov),
conducted between September 2009 and December
2013 in Benin, Gabon, Mozambique and Tanzania.
Participants: Of 4749 participants, pregnancy
outcomes were collected for 4388 deliveries with
4183 live births including 83 multiple gestations.
Of 4100 mothers with a singleton live birth delivery,
24% (975/4100) were adolescents (≤19 years of age)
and 6% (248/4100) were aged ≤16 years.
Primary and secondary outcome measures:
Primary outcomes of this predefined analysis were
preterm delivery and low birth weight.
Results: The overall prevalence of low birthweight
infants and preterm delivery was 10% (371/3851)
and 4% (159/3862), respectively. Mothers aged
≤16 years showed higher risk for the delivery of a
low birthweight infant (OR: 1.96; 95% CI 1.35 to
2.83). Similarly, preterm delivery was associated with
young maternal age (≤16 years; OR: 2.62; 95% CI
1.59 to 4.30). In a subanalysis restricted to
primiparous women: preterm delivery, OR 4.28; 95%
CI 2.05 to 8.93; low birth weight, OR: 1.29; 95% CI
0.82 to 2.01.
Conclusions: Young maternal age increases the risk
for adverse pregnancy outcomes and it is a stronger
predictor for low birth weight and preterm delivery
than other established risk factors in sub-Saharan
Africa. This finding highlights the need to improve
adolescent reproductive health in sub-Saharan Africa.
Trial registration number: NCT00811421;
Post-results.
In summary, this large prospective clinical trial
provides conclusive evidence that young adoles-
cent girls are at considerably higher risk for pre-
mature and low birth weight deliveries in
sub-Saharan Africa. From a public health per-
spective, young adolescent pregnant women
constitute an easily identiﬁable patient popula-
tion amenable to targeted antenatal care pro-
grammes. Development of tailored antenatal
care and facilitation of early attendance of ante-
natal care by young adolescent girls should
therefore become a priority to improve adoles-
cent health in sub-Saharan Africa.
Strengths and limitations of this study
▪ Prospective design.
▪ Highly standardised data collection and follow-up
of participants in diverse African sub-regions.
▪ The setting of a randomised controlled trial
ensured high coverage of standard antenatal care
including vitamin and micronutrient supplemen-
tation, insecticide treated bed nets and availabil-
ity of healthcare without access barriers.
▪ Inclusion of only HIV-negative pregnant women
constituting a limitation for external validity.
▪ The interplay between risk factors for adverse
pregnancy outcome is complex and residual con-
founding may not be completely ruled out.
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INTRODUCTION
Improving maternal and neonatal health is among
Africa’s most urgent challenges in public health.1 2 The
excess rate of maternal and neonatal morbidity and mor-
tality derives from multiple causes in sub-Saharan Africa
including endemic infectious diseases, malnutrition and
micronutrient deﬁciencies, gynaecological and obstetric
complications with suboptimal antenatal and perinatal
as well as often inadequate postnatal care caused by a
lack of adequate ﬁnancial and logistic resources.2–4
Targeted public health interventions such as intermittent
preventive treatment of malaria in pregnancy (IPTp),
vitamin and micronutrient supplementation, provision of
long-lasting insecticide-treated nets (LLITNs), prevention
of mother-to-child HIV transmission and improved fre-
quency and quality of gynaeco-obstetric healthcare are
the cornerstones of current strategies to reduce adverse
pregnancy outcomes in Africa.5–8
It is well known that the risk for adverse pregnancy out-
comes is distributed highly unevenly within populations.
Further reductions of maternal and neonatal morbidity
and mortality can therefore be achieved most efﬁciently
by the identiﬁcation of those individuals most at risk.9
With 44% of its population aged below 15 years,
sub-Saharan Africa is the youngest region in the world.10
However, from a medical and public health perspective,
adolescence is a largely neglected period of life. Few epi-
demiological studies in Africa focus on this period of life
and targeted public health programmes addressing the
most important challenges for adolescent health and
well-being are lacking.
Sexual and reproductive health is arguably among the
most vital health challenges for adolescents in sub-Saharan
Africa.11 Although some regions in sub-Saharan Africa are
characterised by a high proportion of very young pregnant
women, it is currently unclear whether these young girls
beneﬁt equally from established routine antenatal care
programmes or whether more targeted programmes
would be necessary to address speciﬁc needs of this vul-
nerable group of pregnant women.
On the basis of previous retrospective studies, this
study was designed to evaluate prospectively whether
young maternal age may serve as an easily recognisable
predictor for adverse pregnancy outcome in sub-Saharan
Africa. This hypothesis was assessed in the context of a
clinical trial with access to a package of free and high
quality routine antenatal care, effective preventive treat-
ment of malaria in pregnancy, and provision of LLITNs.
MATERIALS AND METHODS
Pregnant women and their offspring participated in a
randomised controlled trial assessing alternative drugs
for intermittent preventive treatment of malaria in preg-
nancy (MiPPAD; NCT00811421—Clinical Trials.gov).12
This study was conducted in four African countries
between September 2009 and December 2013, involving
regions from Western, Eastern, Central and Southern
sub-Saharan Africa. Pregnant women were recruited at
their ﬁrst antenatal visit if they were HIV-negative, pre-
sented with a gestational age below 28 weeks of gestation
at their ﬁrst antenatal care visit, and were willing to par-
ticipate in the study and give birth in the study health
facility. Exclusion criteria were a history of allergy to any
of the study drugs or any other ongoing serious condi-
tion. All women received LLITNs and were randomly
allocated to either standard sulfadoxine-pyrimethamine
or meﬂoquine preventive treatment for malaria. Women
were followed up until 1 month after delivery and infants
were followed up until their ﬁrst anniversary. All costs
for antenatal and postnatal care and transport to respect-
ive health facilities were free of charge for participants.
Participants’ baseline information was recorded at
recruitment including maternal age, weight, height,
mid-upper arm circumference (MUAC), date of last
menstruation and gestational age by bimanual palpation,
obstetrical history, syphilis test (rapid plasma reagin
(RPR) testing), haemoglobin level, literacy as ability to
read and/or write. Body mass index (BMI) was cate-
gorised for further statistical analysis using predeﬁned
threshold levels by the WHO (underweight: BMI<18.5;
normal weight: BMI 18.5–24.9; overweight: BMI 25.0–
29.9; obese: BMI≥30.0). The cut-off for the MUAC was
deﬁned as 240 mm according to the UNICEF
recommendations.13
Gestational age, birth outcome and characteristics of
delivery were recorded at delivery and haemoglobin
levels were assessed from ﬁnger-prick or venous blood
using the HemoCue device (http://www.eurotrol.com).
Infection with Plasmodium falciparum at delivery was
deﬁned as the detection of malaria parasites in periph-
eral blood or placental samples collected at delivery.
Parasitological assessments were performed from periph-
eral and cord blood, as well as from placenta by thick
and thin smears and impression smears, respectively.
Maternal age was calculated from the date of birth
recorded in an ofﬁcial health booklet at enrolment or in
case of lack of documentation by self-reported date of
birth. Adolescence was deﬁned as per the WHO deﬁn-
ition, ‘young individuals between the ages of 10 and 19
years’.14 Maternal age was divided into four categories
including young adolescents aged ≤16 years, adolescents
aged 17–19 years, adults aged 20–30 years and those
aged 31 years and above. The sample size of the data set
supported the use of such stratiﬁcation in all analyses.
The main delivery end points for this analysis were the
proportions of low birthweight infants and preterm
delivery and secondarily the proportion of maternal
anaemia at delivery. Low birth weight was deﬁned as
<2500 g and was measured within the 24 hours after
birth using digital infant scales. Scales were calibrated
weekly and quality controlled. In case of home deliveries
or other reasons for delayed measurement of birth
weight, data were imputed using a previously published
regression model.15 Premature delivery was deﬁned as
delivery before 37 weeks of gestation. Gestational age at
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recruitment was determined from the measure of the
symphysis-fundus height by bimanual palpation at the
ﬁrst antenatal visit. At delivery, gestational age was
assessed by the Ballard Score.16 Anaemia was deﬁned as
haemoglobin level <11 g/dL.
Statistical analysis, conceptual framework and causal
diagram
Several factors including socioeconomic disadvantage,
low BMI and MUAC, primiparity and non-attendance of
antenatal care visits have been described as risk factors
associated with poor birth outcomes. These factors
could therefore potentially confound any observed asso-
ciation between young adolescent pregnancy and
adverse pregnancy outcome and were therefore
included in statistical analysis. A simpliﬁed illustration of
the conceptual framework built up to guide this analysis
is shown in ﬁgure 1.
Statistical analyses were restricted to singleton births
and were conducted using Stata IC/V.13.1 for Windows
(StataCorpLp, College station, Texas, USA). The distri-
bution of baseline characteristics was described and
compared according to maternal age groups. Univariate
analysis was performed to assess the crude association
between maternal age and low birth weight or preterm
delivery. In addition, other variables associated with
higher odds for low birth weight, prematurity and mater-
nal anaemia were identiﬁed. Variables associated with
adverse birth outcomes and maternal age were consid-
ered potential confounders. In a further step, logistic
regression models adjusting for potential confounders
or other covariables were constructed according to their
effect on the point estimate rather than providing p
values. As a guide, the change in the point estimate was
considered signiﬁcant if equal to or above 10%—an
arbitrary cut-off level. We performed stepwise removal of
variables in the absence of evidence for an effect on the
point estimate.17 However, forced variables (country,
treatment arm) were deﬁned and kept in the ﬁnal
model whatever their effect on the point estimate was as
these were inherent to the study design. The ﬁnal model
evaluated the adjusted ORs of adverse birth outcome in
the different age groups. For the analysis of preterm
delivery, data from Tanzania were excluded because of a
systematic error in the assessment of gestational age by
the Ballard score at this study site.
Ethical considerations
All women participating in the study had signed a
written informed consent form before any study related
procedure was performed. The study was conducted
according to the International Conference for harmon-
ization of Good Clinical Practice (ICH-GCP) principles
and the Declaration of Helsinki.
RESULTS
A total of 14 179 pregnant women attending antenatal
clinics in Benin, Gabon, Mozambique and Tanzania
were screened between September 2009 and December
Figure 1 Conceptual framework of risk factors of adverse pregnancy outcome (APO). Orange boxes are categories of risk
factors of Adverse Pregnancy Outcome (APO) have been categorised (orange boxes). The red boxes are the risk factors
discussed throughout this paper. The grey boxes represent known risk factors of APO which were not addressed in this paper.
Mombo-Ngoma G, et al. BMJ Open 2016;6:e011783. doi:10.1136/bmjopen-2016-011783 3
Open Access
 o
n
 14 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2016-011783 on 29 June 2016. Downloaded from 
2012 for recruitment to the MiPPAD trial and 4749 were
randomised at the four study sites. Among those, 361
(7.6%) were lost or withdrawn before delivery, with 79
(22%) adolescents, 237 (66%) women aged between 20
and 30 years and 45 (12%) women aged 31 years or
more. There was no signiﬁcant difference observed in
baseline characteristics between the women lost or with-
drawn from the study and those considered in the ana-
lysis for this study (see online supplementary ﬁgure S1).
Of the 4388 recorded deliveries, 4183 were living births
including 83 multiple gestations. Mother–child pairs of
4100 singleton infants constitute the population of the
primary analysis of this report. Details of the participant
ﬂow are depicted in ﬁgure 2.
Among 4100 pregnant participants with a singleton
live birth, 24% (975/4100) were adolescents with 6%
(248/4100) aged ≤16 years. There was a signiﬁcant dif-
ference in the proportion of adolescent mothers
between countries (table 1). Signiﬁcant differences
between maternal age groups were identiﬁed according
to the period of the ﬁrst antenatal visit as adolescent
women attended earlier compared to other age groups.
Differences were also apparent for parity, nutritional
status, literacy, baseline anaemia and syphilis infection at
ﬁrst presentation to antenatal care clinics (table 1).
Owing to the randomisation, there was no difference in
the allocation to respective intermittent preventive treat-
ment groups (table 1).
Among singleton live births, the overall proportion of
low birthweight infants and preterm delivery was 10%
(371/3851) and 4% (159/3862), respectively. The pro-
portion of women with maternal anaemia at delivery was
41% (1586/3884).
At delivery, very young maternal age (≤16 years) was
the variable with the highest risk for the delivery of a
low birthweight infant, 16% (39/248) compared to adult
mothers aged 20–30 years, 9% (207/2376) (crude OR:
1.96; 95% CI 1.35 to 2.83) (table 2). Other factors sig-
niﬁcantly associated with increased risk for low birth
weight were country, trimester of ﬁrst antenatal visit,
parity, BMI and MUAC (table 2). Similarly, preterm
birth was most closely associated with very young mater-
nal age ≤ 16 years (OR: 2.62; 95% CI 1.59 to 2.13).
Other factors signiﬁcantly associated with preterm birth
were country, BMI and literacy (table 2).
Multivariable risk factors analysis was performed to
assess confounding and potential causal relationships of
covariables. After controlling for country, trimester of
ﬁrst antenatal visit, treatment group and infant gender,
there remained strong evidence for increased odds for
low birth weight in very young adolescent mothers
(≤16 years), OR 2.06 (1.37 to 3.12). However, this associ-
ation was weaker when controlling for BMI, parity, liter-
acy, plasmodium infection and MUAC (table 3).
Conversely, preterm delivery remained signiﬁcantly asso-
ciated with young maternal age in multivariate analysis,
OR 2.16 (1.10 to 4.24) (table 3). Maternal anaemia was
not associated with respective age groups (see online
supplementary tables S1 and S2).
A subanalysis restricted to primiparous women was
performed to control for parity, which is a well-
established risk factor for adverse pregnancy outcome
and which inherently is associated with maternal age.
This restricted analysis demonstrated that very young
maternal age was associated with higher risk for adverse
pregnancy outcome (preterm delivery: OR 4.28; 95% CI
2.05 to 8.93; low birth weight: OR: 1.29; 95% CI 0.82 to
2.01) (see online supplementary table S3).
DISCUSSION
The identiﬁcation of high-risk groups among pregnant
women is of high priority to develop cost-effective inter-
ventions to further reduce maternal and neonatal mor-
tality in sub-Saharan Africa. In this prospective
multinational cohort of pregnant women in sub-Saharan
Africa, young maternal age was the strongest predictor
for adverse pregnancy outcome. Very young mothers
were more likely than their older peers to deliver prema-
turely or a low birthweight infant—two of the key surro-
gate markers for adverse pregnancy outcome and infant
mortality.9 18 19
Our ﬁnding is supported by previous reports from
other geographical and socioeconomic settings demon-
strating a higher than normal risk for teenagers in preg-
nancy.20 21 Several hypotheses have been previously
proposed to explain the higher risk for adverse preg-
nancy outcomes in this group of pregnant women
including social and economic disadvantage, behav-
ioural factors increasing the risk for adverse pregnancy
outcome and biological immaturity of the mother.22 InFigure 2 Participants flow. GA, gestational age.
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this analysis, there was no difference in literacy, nutri-
tional status or syphilis prevalence between young and
older pregnant women. In addition antenatal care was
provided uniformly during the conduct of the clinical
trial excluding differences in healthcare-related
effects. Importantly, this study was not designed to
investigate underlying causes for adverse pregnancy
outcome. Conversely, the aim of this study was to
assess whether young maternal age may be used as a
simple predictive marker for a population at high risk
for adverse pregnancy outcome in sub-Saharan Africa
and to allow for future targeted interventions in this
at-risk group.
Interestingly, young maternal age showed a stronger
association with adverse pregnancy outcome than other
established risk factors including parity or malaria infec-
tion in univariate analysis. In regions of high malaria
transmission, it is estimated that plasmodial infections
may cause about 19% of low birth weight deliveries.23
Malaria infection was highly prevalent in this study in
Gabon and Benin, and these two countries concordantly
had the highest incidence of low birth weight. It is also
well established that the impact of malaria in pregnancy
is highest in primigravid women.24 Whereas this was
similarly observed in this cohort of pregnant women, an
analysis restricted to primigravid women still demon-
strated an excess risk for low birth weight and preterm
delivery in young adolescent mothers stressing the
importance of young maternal age as a risk factor. In
addition, multivariable analysis indicated that young
maternal age is signiﬁcantly associated with premature
delivery. These data unequivocally demonstrate that
young maternal age constitutes a risk factor for adverse
birth outcome. On the basis of these data, it is evident
that young adolescent girls are a readily identiﬁable
at-risk population in sub-Saharan Africa.
Young adolescent pregnancy rates differ considerably
between countries. In this study, high rates were
observed in Gabon and Mozambique, and lower rates
were found in Benin and Tanzania. This difference is
mainly explained by sociocultural and religious determi-
nants of societies. This fact also highlights that young
Table 1 Distribution of baseline characteristics by maternal age group
Maternal age (years)
Overall 14–16 17–19 20–30 31+ p Value
N=4100 (n=248) (n=727) (n=2400) (n=725) (χ2 test)
Country
Benin 1027 5 (0.5) 98 (9.5) 754 (73.4) 170 (16.6) <0.001
Gabon 953 79 (8.3) 221 (23.2) 462 (48.5) 191 (20.0)
Mozambique 1098 157 (14.3) 277 (25.2) 489 (44.5) 175 (15.9)
Tanzania 1022 7 (0.7) 131 (12.8) 695 (68.0) 189 (18.5)
First ANC visit
First trimester 298 22 (8.9) 66 (9.1) 161 (6.7) 49 (6.8) 0.005
Second trimester 2899 186 (75.0) 522 (71.9) 1667 (69.5) 524 (72.2)
Third trimester 902 40 (16.1) 138 (19.0) 572 (23.8) 152 (21.0)
Parity
Nulliparous 1328 239 (96.4) 548 (75.4) 522 (21.7) 19 (2.6) <0.001
Multiparous 2772 9 (3.6) 179 (24.6) 1878 (78.2) 706 (97.4)
BMI
Underweight 493 30 (12.1) 101 (13.9) 306 (12.8) 56 (7.7) <0.001
Normal 2689 184 (74.2) 548 (75.6) 1572 (65.5) 385 (53.1)
Overweight/obese 915 34 (13.7) 76 (10.5) 521 (21.7) 284 (39.2)
MUAC (mm)
≥240 3312 171 (68.9) 524 (72.4) 1964 (82.1) 653 (90.1) <0.001
<240 776 77 (31.1) 200 (27.6) 427 (17.9) 72 (9.9)
Literacy
Literate 2846 220 (88.7) 626 (86.1) 1527 (63.6) 473 (65.2) <0.001
Illiterate 1254 28 (11.3) 101 (13.9) 873 (36.4) 252 (34.8)
Baseline anaemia
No 1656 94 (37.9) 261 (36.0) 985 (41.2) 316 (43.8) 0.001
Yes 2430 154 (62.0) 463 (64.0) 1408 (58.8) 405 (56.2)
Syphilis test
Negative 3961 246 (100) 705 (98.7) 2319 (98.8) 691 (97.2) 0.001
Positive 57 0 (0) 9 (1.3) 28 (1.2) 20 (2.8)
IPTp
MQ 2720 166 (66.9) 479 (65.9) 1599 (66.6) 476 (65.7) 0.95
SP 1380 82 (33.1) 248 (34.1) 801 (33.4) 249 (34.3)
ANC, antenatal clinic; BMI, body mass index; IPTp, intermittent preventive treatment of malaria in pregnancy; MQ, mefloquine; MUAC,
mid-upper arm circumference; SP, sulfadoxine-pyrimethamine.
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adolescent pregnancies may not be of similar public
health importance in all sub-Saharan African countries.
In countries with high proportions of young adolescent
pregnancies, the establishment of dedicated antenatal
care programmes may therefore be of comparatively
higher public health importance to improve maternal,
neonatal and adolescent health.
The major strengths of this study were its prospective
design and the highly standardised data collection and
follow-up of participants in diverse African sub-regions.
In addition, the setting of a randomised controlled trial
ensured high coverage of standard antenatal care includ-
ing vitamin and micronutrient supplementation,
insecticide-treated bednets and availability of healthcare
without access barriers. However, this analysis is not
without limitations. Importantly, this study only included
HIV negative pregnant women willing to participate in
the main clinical trial, constituting a limitation for the
external validity of this study. Furthermore, the interplay
between risk factors for adverse pregnancy outcome is
Table 2 Incidence of low birth weight and preterm birth and univariate analysis of the risk factors
Birth weight Preterm birth
Parameters
Singleton
live
births, N
LBW, n
(%)
Unadjusted OR
(95% CI)
p Value
(LRT)
Singleton
live
births, N
Preterm,
n (%)
Unadjusted OR
(95% CI)
p
Value
(LRT)
Maternal age (years)
14–16 248 39 (15.7) 1.96 (1.35 to 2.83) 214 20 (9.4) 1.82 (1.09 to 3.03)
17–19 714 98 (13.7) 1.67 (1.29 to 2.15) <0.001 543 35 (6.4) 1.22 (0.81 to 1.83) 0.15
20–30 2376 207 (8.7) 1 1548 83 (5.4) 1
≥31 718 47 (6.6) 0.73 (0.53 to 1.02) 486 26 (5.4) 1.00 (0.63 to 1.57)
Country
Benin 1019 108 (10.6) 1.37 (1.01 to 1.84) 923 50 (5.4) 1
Gabon 929 119 (12.8) 1.70 (1.27 to 2.27) 0.0002 886 50 (5.6) 1.04 (0.70 to 1.56) 0.56
Mozambique 1092 87 (8.0) 1 982 64 (6.5) 1.21 (0.83 to 1.78)
Tanzania 1016 77 (7.6) 0.95 (0.69 to 1.30) NA NA NA
First ANC visit
First trimester 292 35 (12.0) 1.66 (1.08 to 2.55) 224 16 (7.1) 1.51 (0.82 to 2.79)
Second
trimester
2868 288 (10.0) 1.36 (1.03 to 1.79) 0.03 1865 114 (6.1) 1.28 (0.86 to 1.89) 0.33
Third trimester 895 68 (7.6) 1 701 34 (4.8) 1
Parity
Nulliparous 1314 182 (13.8) 1.95 (1.58 to 2.40) <0.0001 835 54 (6.5) 1.16 (0.83 to 1.62) 0.39
Multiparous 2742 209 (7.6) 1 1956 110 (5.6) 1
BMI
Normal 2663 264 (9.9) 1 1620 117 (6.1) 1
Underweight 488 80 (16.4) 1.78 (1.35 to 2.33) <0.0001 372 24 (6.4) 1.06 (0.67 to 1.67) 0.39
Overweight/
obese
902 47 (5.2) 0.50 (0.36 to 0.69) 496 23 (4.6) 0.75 (0.47 to 1.18)
MUAC (mm)
≥240 3277 272 (8.3) 1 2199 128 (5.8) 1
<240 767 119 (15.5) 2.03 (1.61 to 2.56) <0.0001 586 36 (6.1) 1.06 (0.72 to 1.55) 0.77
Literacy
Literate 2811 262 (9.3) 1 1725 96 (5.6) 1
Illiterate 1245 129 (10.4) 1.12 (0.90 to 1.40) 0.33 1066 68 (6.4) 1.16 (0.84 to 1.59) 0.38
Plasmodial infection at delivery
No 3682 344 (9.3) 1 2580 1449 (5.8) 1
Yes 197 27 (13.7) 1.54 (1.01 to 2.35) 0.05 174 9 (5.2) 0.89 (0.44 to 1.78) 0.74
IPTp
MQ 2686 260 (9.7) 1 1845 111 (6.0) 1
SP 1370 131 (9.6) 0.99 (0.79 to 1.23) 0.9 946 53 (5.6) 0.93 (0.66 to 1.30) 0.66
Baseline anaemia
No 1646 149 (9.0) 1 1016 69 (6.8) 1
Yes 2396 242 (10.1) 1.13 (0.91 to 1.40) 0.4 1764 95 (5.4) 0.78 (0.57 to 1.08) 0.13
Syphilis test
Negative 3921 379 (9.7) 1 2723 156 (5.7) 1
Positive 55 5 (9.1) 0.93 (0.37 to 2.36) 0.88 39 5 (12.8) 2.42 (0.93 to 6.27) 0.103
ANC, antenatal clinic; BMI, body mass index; IPTp, intermittent preventive treatment of malaria in pregnancy; LRT, likelihood ratio; MQ,
mefloquine; MUAC, mid-upper arm circumference; NA, not applicable; SP, sulfadoxine-pyrimethamine.
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Table 3 Multivariate analysis of risk factors associated with low birth weight and preterm delivery
Birth weight Preterm birth
Parameters
Adjusted Model 1* OR
(95% CI)
p Value
(LRT)
Adjusted final Model
OR (95% CI)
p Value
(LRT)
Adjusted Model 1† OR
(95% CI)
p Value
(LRT)
Adjusted final Model
OR (95% CI)
p Value
(LRT)
Maternal age (years)
14–16 2.06 (1.37 to 3.12) 1.29 (0.81 to 2.06) 1.73 (1.01 to 2.98) 2.16 (1.10 to 4.24)
17–19 1.74 (1.33 to 2.30) <0.0001 1.28 (0.93 to 1.75) 0.48 1.18 (0.77 to 1.81) 0.19 1.41 (0.85 to 2.35) 0.18
20–30 1 1 1 1
≥31 0.73 (0.52 to 1.03) 0.85 (0.60 to 1.20) 0.92 (0.57 to 1.49) 0.88 (0.51 to 1.36)
BMI
Normal 1 1
Underweight 1.72 (1.29 to 2.29) <0.0001 1.49 (1.09 to 2.03) 0.001
Overweight/
obese
0.52 (0.28 to 0.67) 0.65 (0.46 to 0.92)
Literacy
Literate 1 0.80 1 0.17 1 0.14 1 0.11
Illiterate 1.04 (0.78 to 1.38) 1.23 (0.91 to 1.66) 1.35 (0.91 to 2.01) 1.43 (0.94 to 2.16)
Baseline anaemia
No 1 0.18 1 0.14
Yes 0.80 (0.57 to 1.11) 0.79 (0.56 to 1.10)
Plasmodial infection at delivery
Negative 1 0.07 1 0.40 1 0.89 1 0.81
Positive 1.38 (0.89 to 2.12) 1.21 (0.78 to 1.88) 0.95 (0.47 to 1.92) 0.93 (0.46 to 1.88)
Parity
Nulliparous 2.03 (1.62 to 2.53) <0.0001 1.64 (1.23 to 2.19) 0.001 1.10 (0.77 to 1.56) 0.6 0.83 (0.51 to 1.36) 0.47
Multiparous 1 1 1 1
MUAC (mm)
>240 1 <0.0001 1 0.05
<240 1.84 (1.44 to 2.36) 1.32 (1.00 to 1.74)
*Adjusted for country, antenatal clinic; BMI: body mass index; MUAC: mid-upper arm circumference.
†Adjusted for country, first antenatal clinic visit, treatment group and infant gender.
ANC, antenatal clinic; BMI, body mass index; IPTp, intermittent preventive treatment of malaria in pregnancy; LRT, likelihood ratio; MQ, mefloquine; MUAC, mid-upper arm circumference;
SP, sulfadoxine-pyrimethamine.
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complex and residual confounding may not be com-
pletely ruled out. To minimise this risk, multivariable
analysis and restricted analysis of data have been per-
formed, supporting the univariate ﬁndings.
In summary, this large prospective clinical trial pro-
vides conclusive evidence that young adolescent girls are
at considerably higher risk for premature and low birth
weight deliveries in sub-Saharan Africa. From a public
health perspective, young adolescent pregnant women
constitute an easily identiﬁable patient population
amenable to targeted antenatal care programmes.
Development of tailored antenatal care and facilitation
of early attendance of antenatal care by young adoles-
cent girls should therefore become a priority to improve
adolescent health in sub-Saharan Africa.
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